Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
168 hedge funds and large institutions have $1.83B invested in Immunomedics Inc in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 55 reducing their positions, and 16 closing their positions.
75% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 16
11% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 55
7% more funds holding
Funds holding: 157 → 168 (+11)
8% more call options, than puts
Call options by funds: $88M | Put options by funds: $81.2M
8% less capital invested
Capital invested by funds: $1.99B → $1.83B (-$158M)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$49.2M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$14.3M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$14.3M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$12.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$57.1M |
| 2 |
O
OrbiMed
New York
|
-$44.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$42.7M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$14.7M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$14.5M |
IMMU Hedge Fund Activity: Q1 2018 in Review
168 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2018, worth a combined $1.83B — down 7.9% from $1.99B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new IMMU positions and 16 closed out — a net gain of 12 holders — while 61 added to existing stakes and 55 trimmed.
The largest buyer was Vanguard Group, adding an estimated $52M. The largest seller was Millennium Management, cutting an estimated $57.1M.
- 168 institutional investors held Immunomedics Inc (IMMU) as of Q1 2018, up from 157 in Q4 2017.
- Funds reported $1.83B of Immunomedics Inc stock for Q1 2018, down 7.9% quarter-over-quarter.
- 28 funds opened new Immunomedics Inc positions in Q1 2018 and 16 closed out, a net change of +12 holders.
- The largest Immunomedics Inc buyer in Q1 2018 was Vanguard Group, an estimated $52M added.
- The largest Immunomedics Inc seller in Q1 2018 was Millennium Management, an estimated $57.1M sold.
Based on aggregated 13F filings for Q1 2018.